Summary
A pharmaceutical company claimed business deductions for freebies supplied to doctors, arguing that medical ethics rules bound recipients rather than donors and that the 2012 tax circular could not apply earlier. The Court held that supplying incentives whose receipt doctors were legally forbidden to accept fell within expenditure prohibited by law under Explanation 1 to Section 37(1). The circular clarified the existing position from the regulatory prohibition effective 14 December 2009. The appeal against disallowance was dismissed.
Issues
- Whether the absence of a corresponding disciplinary provision against the pharmaceutical donor permitted a deduction.
- Whether the 2012 CBDT circular merely clarified the prohibition applicable from December 2009.
- Whether business-loss and compelled-ransom precedents supported the claimed expenditure.
Provisions considered
- Section 37(1), Explanation 1, Income-tax Act, 1961The expenditure incurred in supplying prohibited freebies to medical practitioners was not deductible. (¶¶ 17, 22-27, 32-37)
- Regulation 6.8.1(a)-(d), Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002The prohibitions on doctors accepting gifts, travel, hospitality and individual monetary benefits informed the tax treatment of the supplier’s expenditure. (¶¶ 18, 24-28, 36)
- Paragraphs 1-4, CBDT Circular No.5/2012 dated 1 August 2012The circular was clarificatory and applied from implementation of the relevant regulatory prohibition on 14 December 2009. (¶ 19)
- Section 23, Indian Contract Act, 1872The Court also treated arrangements supplying freebies to induce prescriptions as contrary to the statutory prohibition and public policy. (¶¶ 31, 35-36)
Held
- Explanation 1 is not confined to expenditure on the illustrative offences mentioned when it was enacted. Its prohibition covers the company’s knowing participation in supplying benefits which medical practitioners cannot lawfully receive. (¶¶ 17, 22, 24)
- The inability of the medical regulator to impose the same disciplinary sanctions on pharmaceutical companies did not create a right to deduct the expenditure. Denial of the tax benefit was not the imposition of a separate criminal punishment on the donor. (¶¶ 24-27, 36)
- The 2012 circular clarified rather than enlarged the relevant tax prohibition. Its application followed the regulatory change effective 14 December 2009, and the claim to deduct the later expenditure for the whole assessment year failed. (¶¶ 4, 19, 37)
- Allowing the deduction would undermine the statutory medical-ethics regime and public policy. The agreements also offended Section 23; the donor could not evade the prohibition governing receipt through a narrow reading of the tax provision. (¶¶ 27-31, 33-36)
- The heroin case concerned a business loss rather than expenditure under Section 37(1), and the ransom case involved a coerced payment to save an employee rather than voluntary participation in prohibited activity. Those decisions did not assist Apex. The appeal was dismissed without costs. (¶¶ 32, 37)
Result
Appeal dismissed without costs; the challenged disallowance of expenditure on prohibited freebies upheld. Pending applications disposed of.